A Phase 3 Multicenter, Open Label, Randomized Study of XL119 Versus 5-Fluorouracil (5-FU) Plus Leucovorin (LV) in Subjects With Advanced Biliary Tumors Not Amenable to Conventional Surgery
Phase of Trial: Phase III
Latest Information Update: 11 Sep 2013
At a glance
- Drugs Becatecarin (Primary) ; Fluorouracil; Folic acid
- Indications Biliary cancer
- Focus Registrational; Therapeutic Use
- Sponsors Exelixis; Helsinn
- 21 Nov 2012 New source identified and integrated (German Clinical Trials Register, DRKS00004071).
- 13 Jan 2009 Added actual trial completion date, as reported by ClinicalTrials.gov.
- 21 Nov 2006 Status change